Immune checkpoint blockades, or ICBs, have revolutionized treatment for various advanced cancers. However, their ...

Immune checkpoint blockades, or ICBs, have revolutionized treatment for various advanced cancers. However, their effectiveness has plateaued due to therapeutic resistance that renders ...

DAEJEON, Dec. 12 (Korea Bizwire) – South Korean researchers have developed a new messenger RNA (mRNA) treatment that can ...

Since the development of CAR (chimeric antigen receptor)-T cell therapies for treating blood cancers, anticancer cellular therapies for solid tumors have been steadily developed. Tumor-infiltrating T ...

Fibroblastic reticular cells (FRCs) create T-cell-supportive niches within lung cancer tumors, facilitating T-cell migration, ...

Iovance Biotherapeutics, Inc. is gaining momentum with impressive sales growth, analyst support, and a strong balance sheet.

The first poster compared the impact of stromal tumor-infiltrating lymphocytes (sTILs ... Indicators of the systemic immune ...

Preclinical studies showed that the addition of IL-15 could improve the performance of CAR T cell-based immunotherapies.

CD8+ T cell infiltration also correlated with a marked reduction ... The details about the poster presentation are as follows: Abstract Number: SESS-1069 Title: Bria-IMT CD8+ tumor infiltrating ...

Therapeutics highlights the infiltration of cancer fighting immune cells into tumors, using leading CD8 ImmunoPET imaging ...